BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26833356)

  • 1. Mito-priming as a method to engineer Bcl-2 addiction.
    Lopez J; Bessou M; Riley JS; Giampazolias E; Todt F; Rochegüe T; Oberst A; Green DR; Edlich F; Ichim G; Tait SW
    Nat Commun; 2016 Feb; 7():10538. PubMed ID: 26833356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Mito-Priming to Generate BCL-2 Addicted Cells.
    Lopez J; Tait SWG
    Methods Mol Biol; 2019; 1877():45-60. PubMed ID: 30535997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.
    Kazi A; Sun J; Doi K; Sung SS; Takahashi Y; Yin H; Rodriguez JM; Becerril J; Berndt N; Hamilton AD; Wang HG; Sebti SM
    J Biol Chem; 2011 Mar; 286(11):9382-92. PubMed ID: 21148306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct lipid effects on tBid and Bim activation of membrane permeabilization by pro-apoptotic Bax.
    Shamas-Din A; Bindner S; Chi X; Leber B; Andrews DW; Fradin C
    Biochem J; 2015 May; 467(3):495-505. PubMed ID: 25714678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MOMP in the absence of BH3-only proteins.
    García Sáez AJ; Villunger A
    Genes Dev; 2016 Apr; 30(8):878-80. PubMed ID: 27083995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BH3 domains other than Bim and Bid can directly activate Bax/Bak.
    Du H; Wolf J; Schafer B; Moldoveanu T; Chipuk JE; Kuwana T
    J Biol Chem; 2011 Jan; 286(1):491-501. PubMed ID: 21041309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BH3 mimetics induce apoptosis independent of DRP-1 in melanoma.
    Mukherjee N; Strosnider A; Vagher B; Lambert KA; Slaven S; Robinson WA; Amato CM; Couts KL; Bemis JGT; Turner JA; Norris DA; Shellman YG
    Cell Death Dis; 2018 Sep; 9(9):907. PubMed ID: 30185782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PUMA cooperates with direct activator proteins to promote mitochondrial outer membrane permeabilization and apoptosis.
    Chipuk JE; Green DR
    Cell Cycle; 2009 Sep; 8(17):2692-6. PubMed ID: 19652530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins.
    Zhang S; Long A; Link AJ
    ACS Synth Biol; 2012 Mar; 1(3):89-98. PubMed ID: 23651073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?
    Chipuk JE; Green DR
    Trends Cell Biol; 2008 Apr; 18(4):157-64. PubMed ID: 18314333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The carboxyl-terminal sequence of PUMA binds to both anti-apoptotic proteins and membranes.
    Pemberton JM; Nguyen D; Osterlund EJ; Schormann W; Pogmore JP; Hirmiz N; Leber B; Andrews DW
    Elife; 2023 Apr; 12():. PubMed ID: 37078707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteins.
    Weber A; Paschen SA; Heger K; Wilfling F; Frankenberg T; Bauerschmitt H; Seiffert BM; Kirschnek S; Wagner H; Häcker G
    J Cell Biol; 2007 May; 177(4):625-36. PubMed ID: 17517961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discoveries and controversies in BCL-2 protein-mediated apoptosis.
    Zheng JH; Viacava Follis A; Kriwacki RW; Moldoveanu T
    FEBS J; 2016 Jul; 283(14):2690-700. PubMed ID: 26411300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak.
    Uren RT; Dewson G; Chen L; Coyne SC; Huang DC; Adams JM; Kluck RM
    J Cell Biol; 2007 Apr; 177(2):277-87. PubMed ID: 17452531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance.
    Pécot J; Maillet L; Le Pen J; Vuillier C; Trécesson SC; Fétiveau A; Sarosiek KA; Bock FJ; Braun F; Letai A; Tait SWG; Gautier F; Juin PP
    Cell Rep; 2016 Dec; 17(12):3347-3358. PubMed ID: 28009301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell lymphoma-2 (BCL-2) homology domain 3 (BH3) mimetics demonstrate differential activities dependent upon the functional repertoire of pro- and anti-apoptotic BCL-2 family proteins.
    Renault TT; Elkholi R; Bharti A; Chipuk JE
    J Biol Chem; 2014 Sep; 289(38):26481-26491. PubMed ID: 25096574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
    Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK inhibitors upregulate BH3-only proteins to sensitize human myeloma cells to BH3 mimetic therapies.
    Chen S; Dai Y; Pei XY; Myers J; Wang L; Kramer LB; Garnett M; Schwartz DM; Su F; Simmons GL; Richey JD; Larsen DG; Dent P; Orlowski RZ; Grant S
    Cancer Res; 2012 Aug; 72(16):4225-37. PubMed ID: 22693249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An interconnected hierarchical model of cell death regulation by the BCL-2 family.
    Chen HC; Kanai M; Inoue-Yamauchi A; Tu HC; Huang Y; Ren D; Kim H; Takeda S; Reyna DE; Chan PM; Ganesan YT; Liao CP; Gavathiotis E; Hsieh JJ; Cheng EH
    Nat Cell Biol; 2015 Oct; 17(10):1270-81. PubMed ID: 26344567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53.
    Zhang J; Huang K; O'Neill KL; Pang X; Luo X
    Cell Death Dis; 2016 Jun; 7(6):e2266. PubMed ID: 27310874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.